Ngā hua rapu - Daigo Yoshiga
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
Zoledronic Acid Enhances Lipopolysaccharide-Stimulated Proinflammatory Reactions through Controlled Expression of SOCS1 in Macrophages mā Daichi Muratsu, Daigo Yoshiga, Takaharu Taketomi, Tomohiro Onimura, Yoshihiro Seki, Akinobu Matsumoto, Seiji Nakamura
I whakaputaina 2013Artigo -
2
-
3
-
4
Spred-1 Negatively Regulates Interleukin-3-mediated ERK/Mitogen-activated Protein (MAP) Kinase Activation in Hematopoietic Cells mā Atsushi Nonami, Reiko Kato, Koji Taniguchi, Daigo Yoshiga, Takaharu Taketomi, Satoru Fukuyama, Mine Harada, Atsuo T. Sasaki, Akihiko Yoshimura
I whakaputaina 2004Artigo -
5
Prevalence and imaging characteristics of detectable tonsilloliths on 482 pairs of consecutive CT and panoramic radiographs mā Masafumi Oda, Shinji Kito, Tatsurou Tanaka, Ikuko Nishida, Shuji Awano, Yuko Fujita, Katsura Saeki, Shinobu Matsumoto‐Takeda, Nao Wakasugi‐Sato, Manabu Habu, Shinya Kokuryo, Masaaki Kodama, Takeshi Kaneuji, Daigo Yoshiga, Ikuya Miyamoto, Shun Nishimura, Yoshihiro Yamashita, Kenshi Maki, Kazuhiro Tominaga, Izumi Yoshioka, Toshihiro Ansai, Yasuhiro Morimoto
I whakaputaina 2013Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Immunology
Internal medicine
Medicine
Biology
Cancer research
Chemistry
Inflammation
Cell biology
Lipopolysaccharide
Proinflammatory cytokine
Zoledronic acid
Biochemistry
Bisphosphonate
Bone marrow
Cancer
Cell culture
Cytokine
Dentistry
Endocrinology
Genetics
Haematopoiesis
Immune system
In vitro
Inflammasome
Innate immune system
Insulin
Insulin resistance
Kinase
M2 Macrophage
MAPK/ERK pathway